UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy of Dabrafenib and Trametinib in a Patient with Squamous-Cell Carcinoma, with Mutation p.D594G in BRAF and p.R461 in NF1 Genes-A Case Report with Literature Review

International journal of molecular sciences, 2023-01, Vol.24 (2), p.1195

2023

Volltextzugriff (PDF)

The efficacy of T790M mutation testing in liquid biopsy-Real clinic data

PloS one, 2022-05, Vol.17 (5), p.e0267846-e0267846

2022

Volltextzugriff (PDF)

Tissue MicroRNA Expression as a Predictor of Response to Immunotherapy in NSCLC Patients

Frontiers in oncology, 2021-02, Vol.10, p.563613-563613

2021

Volltextzugriff (PDF)

Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer

AMB Express, 2022-07, Vol.12 (1), p.86-86, Article 86

2022

Volltextzugriff (PDF)

Gut resistome of NSCLC patients treated with immunotherapy

Frontiers in genetics, 2024-08, Vol.15, p.1378900

2024

Volltextzugriff (PDF)

Crizotinib efficacy in advanced non-squamous NSCLC patients with ALK or ROS1 rearrangement

Scientific reports, 2021-10, Vol.11 (1), p.20939-20939, Article 20939

2021

Volltextzugriff (PDF)

Attempting to Identify Bacterial Allies in Immunotherapy of NSCLC Patients

Cancers, 2022-12, Vol.14 (24), p.6250

2022

Volltextzugriff (PDF)

Observational cross-sectional study of 5279 bronchoscopy results for the practical effectiveness of various biopsy techniques in the diagnosis of lung diseases with particular emphasis on lung cancer

BMJ open, 2021-08, Vol.11 (8), p.e043820-e043820

2021

Volltextzugriff (PDF)

An Episode of Pseudothrombocytopenia during Pembrolizumab Therapy in NSCLC Patient

Case reports in oncological medicine, 2020, Vol.2020 (2020), p.1-4

2020

Volltextzugriff (PDF)

Different MET gene alterations in lung adenocarcinoma patients

Oncology in Clinical Practice, 2022-01

2022

Volltextzugriff (PDF)

Risk factors and primary prevention of lung cancer. Cessation of cigarette addiction

Oncology in Clinical Practice, 2021-01, Vol.17 (3), p.112-124

2021

Volltextzugriff (PDF)

Survival analysis of advanced lung cancer patients undergoing personalised treatment or chemotherapy in a real clinic

Archives of medical science, 2021-02

2021

Volltextzugriff (PDF)

Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma

Archives of medical science, 2020, Vol.16 (6), p.1496-1500

2020

Volltextzugriff (PDF)

The impact of ACE gene polymorphism on the incidence and phenotype of sarcoidosis in rural and urban settings

Archives of medical science, 2016-12, Vol.12 (6), p.1263-1272

2016

Volltextzugriff (PDF)

Genetic and geographic influence on phenotypic variation in European sarcoidosis patients

Frontiers in medicine, 2023-08, Vol.10, p.1218106-1218106

2023

Volltextzugriff (PDF)

The effectiveness of chemotherapy in small cell lung cancer patients with BRCA2 gene mutation and Schwartz-Bartter syndrome

Oncology in Clinical Practice, 2019-01, Vol.15 (2), p.120-123

2019

Volltextzugriff (PDF)

TNF-alpha and TNF-beta gene polymorphisms in Polish patients with sarcoidosis. Connection with the susceptibility and prognosis

Sarcoidosis, vasculitis, and diffuse lung diseases, 2010-07, Vol.27 (2), p.131-137

2010

Volltextzugriff (PDF)

Ultrasound findings in cutaneous sarcoidosis: report of a case

Postȩpy dermatologii i alergologii, 2015, Vol.1, p.51-55

2015

Volltextzugriff (PDF)

Current dietary recommendations for patients with cystic fibrosis

Journal of education, health and sport, 2019-04, Vol.9 (4), p.256-264

2019

Volltextzugriff (PDF)

Current dietary recommendations for patients with cystic fibrosis

Journal of education, health and sport, 2019-04, Vol.9 (4)

2019

Volltextzugriff (PDF)

Effectiveness of osimertinib in patients with lung adenocarcinoma in clinical practice - the Expanded Drug Access Program in Poland

Advances in respiratory medicine, 2020-01, Vol.88 (3), p.189-196

2020

Volltextzugriff (PDF)

Differential diagnosis of autoimmune pituitary failure and pituitary macroadenoma during nivolumab therapy in an NSCLC patient — a case report

Oncology in Clinical Practice, 2019-01, Vol.15 (5), p.260-264

2019

Volltextzugriff (PDF)

Predictive and prognostic factors in second- and third-line erlotinib treatment in NSCLC patients with known status of the EGFR gene

Oncology reports, 2013-09, Vol.30 (3), p.1463-1472

2013

Volltextzugriff (PDF)

The clinical significance of interleukin 18 assessment in sarcoidosis patients

Respiratory medicine, 2007-04, Vol.101 (4), p.722-728

2007

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(38)
Berichte
(1)

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Efficacy of Dabrafenib and Trametinib in a Patient with Squamous-Cell Carcinoma, with Mutation p.D594G in BRAF and p.R461 in NF1 Genes-A Case Report with Literature Review

The efficacy of T790M mutation testing in liquid biopsy-Real clinic data

Tissue MicroRNA Expression as a Predictor of Response to Immunotherapy in NSCLC Patients

Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer

Gut resistome of NSCLC patients treated with immunotherapy

Crizotinib efficacy in advanced non-squamous NSCLC patients with ALK or ROS1 rearrangement

Attempting to Identify Bacterial Allies in Immunotherapy of NSCLC Patients

Observational cross-sectional study of 5279 bronchoscopy results for the practical effectiveness of various biopsy techniques in the diagnosis of lung diseases with particular emphasis on lung cancer

An Episode of Pseudothrombocytopenia during Pembrolizumab Therapy in NSCLC Patient

Different MET gene alterations in lung adenocarcinoma patients

Risk factors and primary prevention of lung cancer. Cessation of cigarette addiction

Survival analysis of advanced lung cancer patients undergoing personalised treatment or chemotherapy in a real clinic

Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma

Impact of copy number variant and single nucleotide polymorphism of the programmed death-ligand 1 gene, programmed death-ligand 1 protein expression and therapy regimens on overall survival in a large group of Caucasian patients with non-small cell lung carcinoma

The impact of ACE gene polymorphism on the incidence and phenotype of sarcoidosis in rural and urban settings

Genetic and geographic influence on phenotypic variation in European sarcoidosis patients

The effectiveness of chemotherapy in small cell lung cancer patients with BRCA2 gene mutation and Schwartz-Bartter syndrome

TNF-alpha and TNF-beta gene polymorphisms in Polish patients with sarcoidosis. Connection with the susceptibility and prognosis

Ultrasound findings in cutaneous sarcoidosis: report of a case

Current dietary recommendations for patients with cystic fibrosis

Current dietary recommendations for patients with cystic fibrosis

Effectiveness of osimertinib in patients with lung adenocarcinoma in clinical practice - the Expanded Drug Access Program in Poland

Differential diagnosis of autoimmune pituitary failure and pituitary macroadenoma during nivolumab therapy in an NSCLC patient — a case report

Predictive and prognostic factors in second- and third-line erlotinib treatment in NSCLC patients with known status of the EGFR gene

The clinical significance of interleukin 18 assessment in sarcoidosis patients

Suchergebnisse filtern